• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Ras association domain-containing protein 8 (RASSF8)

ACP14832

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP14832 Target NameRASSF8
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-419Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8NHQ8
Background Information
  • Uniprot Id

    Q8NHQ8

  • Target Species

    Human

  • Target Name

    RASSF8

  • Target Full Name

    Ras association domain-containing protein 8

  • Target Involvement

    A chromosomal aberration involving RASSF8 is found in a complex type of synpolydactyly referred to as 3/3-prime/4 synpolydactyly associated with metacarpal and metatarsal synostoses. Reciprocal translocation t(12;22)(p11.2;q13.3) with FBLN1.

  • Target Tissue Specificity

    Widely expressed as a 6.2 kb transcript. A 2.2 kb alternatively spliced transcript is expressed exclusively in testis.

  • Target Synonyms

    C12orf2; Carcinoma associated HOJ 1; Carcinoma associated protein HOJ 1; Carcinoma-associated protein HOJ-1; HoJ 1; HoJ1; Ras association (RalGDS/AF 6) domain family (N terminal) member 8; Ras association (RalGDS/AF 6) domain family 8; Ras association domain containing protein 8; Ras association domain family 8; Ras association domain-containing protein 8; RASF8_HUMAN; RASSF 8; Rassf8

Inquire Recombinant Human Ras association domain-containing protein 8 (RASSF8) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification